Tag Archives: Schizophrenia

Interview: Mental Healthcare in Private Sector in India — Dr M S Reddy

Dr M S Reddy is director of Asha Bipolar Clinic, Hyderabad, and president of Indian Association of Private Psychiatry (IAPP). He is also a council member of Asian Network of Bipolar Disorders and editor of Indian Journal of Psychological Medicine.

Posted in INTERVIEWS | Tagged , , , , , , , , , , , , , , | Leave a comment

Interview: Dr Nirmala Srinivasan, a disability rights activist who has been fighting a ‘battle without battle lines’

Dr Nirmala Srinivasan, a disability rights advocate and Ashoka fellow, is the founder of FACEMI (Families Alliance on Mental Illness), the first national forum in India for families that are engaged in taking care of treatment, rehabilitation and support of their members suffering from mental illness such as Schizophrenia, Bipolar Disorder (Severe Mental Disorder, SMD) or Common Mental Disorders (CMD) such as Anxiety, Depression, Obsessive-Compulsive Disorder (OCD).

Posted in INTERVIEWS | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Virtual patients developed for training medical students in psychiatry

Visakhapatnam (Andhra Pradesh): Dr C Radhakanth, professor of psychiatry, Maharajah’s Institute of Medical Sciences, Vizianagaram, has developed virtual patients using computer graphics for teaching medical students about post-traumatic stress disorder and bipolar suicidal patient.

Posted in Psychiatry, RESEARCH | Tagged , , , , , , , | Leave a comment

‘Why are we still shamefully insensitive to the plight of the mentally ill?’

“You can judge a society by how well it treats its prisoners.” — Fyodor Dostoevsky
While I concur with this aphorism, I have often wondered whether the great Dostoevsky ever attempted to assess the compassion of a society by the treatment that is meted out to its mentally ill members. And whether he would consider this test just as valid as assessing the prisoners.

Posted in OPINIONS | Tagged , , , , , , , , , , | Leave a comment

Committee to review fire safety guidelines for hospitals | Court seeks report on doctors in Govt hospitals | Medical teachers on hunger strike

In a move to avoid fire accidents in hospitals, the union health ministry has set up a committee to review fire safety guidelines for hospitals.

Posted in MEDICAL NEWS DIGEST | Tagged , , , , , , , , , , , , , , , | Leave a comment

Saving a mentally ill patient from death row

The Pakistan Supreme Court recently ruled that schizophrenia does not qualify as a mental illness as it is a ‘recoverable’ condition. I have not had access to the details of the case which prompted this pearl of judicial wisdom apart from what is available in the Fourth Estate.

Posted in OPINIONS | Tagged , , , , , , , , , , , , , , , , , , , , , , , | 1 Comment

Opinion: Present state of mental health care in India is unacceptable

What does it say about our society when we are unable to extend help to unquestionably the most vulnerable section who cannot speak for themselves? And schizophrenia is not the only illness that invited societal apathy — nearly all the mental illnesses do so in India.

Posted in OPINIONS | Tagged , , , , , , , , | Leave a comment

Key biological markers for psychotic disorders identified

New York: A team of researchers led by the University of Georgia has identified several biological markers that make it possible to classify mental disorders with greater precision.

Posted in Psychiatry, RESEARCH | Tagged , , , , , , | Leave a comment

US FDA approves new injectable drug to treat schizophrenia

Washington: The US Food and Drug Administration has approved Aristada (aripiprazole lauroxil) extended release injection to treat adults with schizophrenia. Aristada is administered by a healthcare professional every four to six weeks using an injection in the arm or buttocks.

Posted in NEWS, Pharmaceuticals | Tagged , , , , , | Leave a comment

Two genes unlock potential for treatment of schizophrenia

Singapore: Research led by scientists from Duke-NUS Graduate Medical School Singapore (Duke-NUS) has linked the abnormal behaviour of two genes (BDNF and DTNBP1) to the underlying cause of schizophrenia. These findings have provided a new target for schizophrenia treatment.

Posted in Neurology, RESEARCH | Tagged , , | Leave a comment